Stocks News

LAST PRICE
217.6400
TODAY'S CHANGE (%)
Trending Down-0.9300 (-0.4255%)

Bid / Lots
---/ ---
Ask / Lots
---/ ---
Open / Previous Close
219.4800 / 218.5700
Day Range
Low 214.8000
High 219.4800
52 Week Range
Low 177.6330
High 262.9700
Volume
392,913
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 13, 2024
- Teleflex Publishes 2023 Global Impact Report, from 6:30AM ET on Monday May 13, 2024 by GlobeNewswire
  6:30AM ET on Monday May 13, 2024 by GlobeNewswire
  Companies Mentioned: TFX
- Teleflex Publishes 2023 Global Impact Report, from 6:30AM ET on Monday May 13, 2024 by Dow Jones
  6:30AM ET on Monday May 13, 2024 by Dow Jones
  Companies Mentioned: TFX
  
  Teleflex Publishes 2023 Global Impact Report
  
  Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program
  
  WAYNE, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2023 Global Impact Report. The report outlines recent accomplishments and sets new targets to support the company's Corporate Social Responsibility (CSR) program and aligns with the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board (SASB), and Taskforce on Climate-Related Financial Disclosures (TCFD).
May 9, 2024
- Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow(TM) EZ-IO(TM) Intraosseous Access Procedure Tray, from 6:30AM ET on Thursday May 09, 2024 by GlobeNewswire
  6:30AM ET on Thursday May 09, 2024 by GlobeNewswire
  Companies Mentioned: TFX
- Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow(TM) EZ-IO(TM) Intraosseous Access Procedure Tray, from 6:30AM ET on Thursday May 09, 2024 by Dow Jones
  6:30AM ET on Thursday May 09, 2024 by Dow Jones
  Companies Mentioned: TFX
  
  Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow(TM) EZ-IO(TM) Intraosseous Access Procedure Tray
  
  The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug Administration
May 7, 2024
- Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift(TM) System Highlight a Superior Patient Experience* Against RezÅ«m and Its Advantage Over Medical Therapy as an Early Intervention for BPH, from 6:30AM ET on Tuesday May 07, 2024 by GlobeNewswire
  6:30AM ET on Tuesday May 07, 2024 by GlobeNewswire
  Companies Mentioned: TFX

May 14, 2024
- Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing, from 5:24PM ET on Tuesday May 14, 2024 by MT Newswires
  5:24PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: GMED
- European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading, from 11:07AM ET on Tuesday May 14, 2024 by MT Newswires
  11:07AM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: ERIC, AVDL, NOK, SNN, SNY, TRIB, VOD, SQNS, AUTL, GNFT, CALT, BHP, SHEL, DBVT, BDRX, EDAP
May 13, 2024
- Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating, from 7:07AM ET on Monday May 13, 2024 by MT Newswires
  7:07AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: GMED
May 10, 2024
- Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing, from 4:52PM ET on Friday May 10, 2024 by MT Newswires
  4:52PM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: GMED
May 9, 2024
- Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating, from 11:57AM ET on Thursday May 09, 2024 by MT Newswires
  11:57AM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: GMED
May 8, 2024
- Sector Update: Health Care Stocks Slipping Wednesday Afternoon, from 1:56PM ET on Wednesday May 08, 2024 by MT Newswires
  1:56PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: PFE, TEVA, GMED
- Sector Update: Health Care, from 1:36PM ET on Wednesday May 08, 2024 by MT Newswires
  1:36PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: GMED
- Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards, from 12:39PM ET on Wednesday May 08, 2024 by MT Newswires
  12:39PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: GMED
- Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating, from 11:00AM ET on Wednesday May 08, 2024 by MT Newswires
  11:00AM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: GMED
- UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating, from 10:19AM ET on Wednesday May 08, 2024 by MT Newswires
  10:19AM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: BIO

Teleflex Inc
NYSE:TFXUnited States

Search Criteria

May 13, 2024

Teleflex Publishes 2023 Global Impact Report, from 6:30AM ET on Monday May 13, 2024 by GlobeNewswire

Teleflex Publishes 2023 Global Impact Report, from 6:30AM ET on Monday May 13, 2024 by Dow Jones

May 9, 2024

Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow(TM) EZ-IO(TM) Intraosseous Access Procedure Tray, from 6:30AM ET on Thursday May 09, 2024 by GlobeNewswire

Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow(TM) EZ-IO(TM) Intraosseous Access Procedure Tray, from 6:30AM ET on Thursday May 09, 2024 by Dow Jones

May 7, 2024

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift(TM) System Highlight a Superior Patient Experience* Against RezÅ«m and Its Advantage Over Medical Therapy as an Early Intervention for BPH, from 6:30AM ET on Tuesday May 07, 2024 by GlobeNewswire

Peers Headlines

May 14, 2024

Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing, from 5:24PM ET on Tuesday May 14, 2024 by MT Newswires

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading, from 11:07AM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating, from 7:07AM ET on Monday May 13, 2024 by MT Newswires

May 10, 2024

Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing, from 4:52PM ET on Friday May 10, 2024 by MT Newswires

May 9, 2024

Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating, from 11:57AM ET on Thursday May 09, 2024 by MT Newswires

May 8, 2024

Sector Update: Health Care Stocks Slipping Wednesday Afternoon, from 1:56PM ET on Wednesday May 08, 2024 by MT Newswires

Sector Update: Health Care, from 1:36PM ET on Wednesday May 08, 2024 by MT Newswires

Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards, from 12:39PM ET on Wednesday May 08, 2024 by MT Newswires

Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating, from 11:00AM ET on Wednesday May 08, 2024 by MT Newswires

UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating, from 10:19AM ET on Wednesday May 08, 2024 by MT Newswires